The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions

The addition of cetuximab to platinum-based chemotherapy (cisplatin or carboplatin plus 5-fluorouracil [5-FU]), followed by maintenance cetuximab until disease progression (EXTREME), resulted in the first regimen to yield significantly improved survival outcomes in the first-line treatment of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Guigay, Joël, Tahara, Makoto, Licitra, Lisa, Keilholz, Ulrich, Friesland, Signe, Witzler, Pauline, Mesía, Ricard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712586/
https://www.ncbi.nlm.nih.gov/pubmed/31497530
http://dx.doi.org/10.3389/fonc.2019.00668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712586/
https://www.ncbi.nlm.nih.gov/pubmed/31497530
http://dx.doi.org/10.3389/fonc.2019.00668

Ejemplares similares